Document Classification

Section Type: RESULTS

Text: Differences in adjusted mean change from baseline HbA1c (95 % CI) were greater with saxagliptin compared with placebo in patients with a history of CVD (-0. 64 % [-0. 90 to -0. 38]) and no history of CVD (-0. 68 % [-0. 78 to -0. 58]) ; with 2 CV risk factors (-0. 73 % [-0. 85 to -0. 60]) and 0 to 1 CV risk factor (-0. 62 % [-0. 75 to -0. 48]) ; with statin use (-0. 70 % [-0. 89 to -0. 52]) and no statin use (-0. 66 % [-0. 77 to -0. 56]) ; and with hypertension (-0. 69 % [-0. 82 to -0. 57]) and no hypertension (-0. 66 % [-0. 80 to -0. 52]).